Synthetic lethal screen identification of chemosensitizer loci in cancer cells (original) (raw)

Nature volume 446, pages 815–819 (2007)Cite this article

Abstract

Abundant evidence suggests that a unifying principle governing the molecular pathology of cancer is the co-dependent aberrant regulation of core machinery driving proliferation and suppressing apoptosis1. Anomalous proteins engaged in support of this tumorigenic regulatory environment most probably represent optimal intervention targets in a heterogeneous population of cancer cells. The advent of RNA-mediated interference (RNAi)-based functional genomics provides the opportunity to derive unbiased comprehensive collections of validated gene targets supporting critical biological systems outside the framework of preconceived notions of mechanistic relationships. We have combined a high-throughput cell-based one-well/one-gene screening platform with a genome-wide synthetic library of chemically synthesized small interfering RNAs for systematic interrogation of the molecular underpinnings of cancer cell chemoresponsiveness. NCI-H1155, a human non-small-cell lung cancer line, was employed in a paclitaxel-dependent synthetic lethal screen designed to identify gene targets that specifically reduce cell viability in the presence of otherwise sublethal concentrations of paclitaxel. Using a stringent objective statistical algorithm to reduce false discovery rates below 5%, we isolated a panel of 87 genes that represent major focal points of the autonomous response of cancer cells to the abrogation of microtubule dynamics. Here we show that several of these targets sensitize lung cancer cells to paclitaxel concentrations 1,000-fold lower than otherwise required for a significant response, and we identify mechanistic relationships between cancer-associated aberrant gene expression programmes and the basic cellular machinery required for robust mitotic progression.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Green, D. R. & Evan, G. I. A matter of life and death. Cancer Cell 1, 19–30 (2002)
    Article CAS Google Scholar
  2. Chien, Y. & White, M. A. RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival. EMBO Rep. 4, 800–806 (2003)
    Article CAS Google Scholar
  3. Matheny, S. A. et al. Ras regulates assembly of mitogenic signalling complexes through the effector protein IMP. Nature 427, 256–260 (2004)
    Article ADS CAS Google Scholar
  4. Malo, N., Hanley, J. A., Cerquozzi, S., Pelletier, J. & Nadon, R. Statistical practice in high-throughput screening data analysis. Nature Biotechnol. 24, 167–175 (2006)
    Article CAS Google Scholar
  5. Benjamini, Y. H. Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B 57, 2890300 (1995)
    MathSciNet MATH Google Scholar
  6. Allison, D. B., Cui, X., Page, G. P. & Sabripour, M. Microarray data analysis: from disarray to consolidation and consensus. Nature Rev. Genet. 7, 55–65 (2006)
    Article CAS Google Scholar
  7. Wit, E. & McClure, J. Statistical adjustment of signal censoring in gene expression experiments. Bioinformatics 19, 1055–1060 (2003)
    Article CAS Google Scholar
  8. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B 57, 289–300 (1995)
    MathSciNet MATH Google Scholar
  9. Jordan, M. A. & Wilson, L. The use and action of drugs in analyzing mitosis. Methods Cell Biol. 61, 267–295 (1999)
    Article CAS Google Scholar
  10. Moritz, M. & Agard, D. A. Gamma-tubulin complexes and microtubule nucleation. Curr. Opin. Struct. Biol. 11, 174–181 (2001)
    Article CAS Google Scholar
  11. Jordan, M. A. & Wilson, L. Microtubules as a target for anticancer drugs. Nature Rev. Cancer 4, 253–265 (2004)
    Article CAS Google Scholar
  12. Scanlan, M. J., Simpson, A. J. & Old, L. J. The cancer/testis genes: review, standardization, and commentary. Cancer Immun. 4, 1–15 (2004)
    PubMed Google Scholar
  13. Toschi, L., Finocchiaro, G., Bartolini, S., Gioia, V. & Cappuzzo, F. Role of gemcitabine in cancer therapy. Future Oncol. 1, 7–17 (2005)
    Article CAS Google Scholar
  14. Weaver, B. A. & Cleveland, D. W. Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death. Cancer Cell 8, 7–12 (2005)
    Article CAS Google Scholar
  15. Ramirez, R. D. et al. Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res. 64, 9027–9034 (2004)
    Article CAS Google Scholar
  16. Rieder, C. L. & Maiato, H. Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev. Cell 7, 637–651 (2004)
    Article CAS Google Scholar
  17. Davies, A. M. et al. Bortezomib-based combinations in the treatment of non-small-cell lung cancer. Clin. Lung Cancer 7, (Suppl 2)S59–S63 (2005)
    Article CAS Google Scholar
  18. Kawasaki-Nishi, S., Nishi, T. & Forgac, M. Proton translocation driven by ATP hydrolysis in V-ATPases. FEBS Lett. 545, 76–85 (2003)
    Article CAS Google Scholar
  19. Boyd, M. R. et al. Discovery of a novel antitumor benzolactone enamide class that selectively inhibits mammalian vacuolar-type (H+)-ATPases. J. Pharmacol. Exp. Ther. 297, 114–120 (2001)
    CAS PubMed Google Scholar
  20. Xie, X. S. et al. Salicylihalamide A inhibits the V0 sector of the V-ATPase through a mechanism distinct from bafilomycin A1. J. Biol. Chem. 279, 19755–19763 (2004)
    Article CAS Google Scholar
  21. Wu, Y., Liao, X., Wang, R., Xie, X. S. & De Brabander, J. K. Total synthesis and initial structure–function analysis of the potent V-ATPase inhibitors salicylihalamide A and related compounds. J. Am. Chem. Soc. 124, 3245–3253 (2002)
    Article CAS Google Scholar
  22. Skehan, P. et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl Cancer Inst. 82, 1107–1112 (1990)
    Article CAS Google Scholar

Download references

Acknowledgements

This work was supported by grants from the National Cancer Institute, the Robert E. Welch Foundation, the Susan G. Komen Foundation, the Department of Defense Congressionally Directed Medical Research Program and the National Cancer Institute Lung Cancer Specialized Program of Research Excellence.

Author information

Authors and Affiliations

  1. Department of Cell Biology,,
    Angelique W. Whitehurst, Brian O. Bodemann, Jessica Cardenas & Michael A. White
  2. Reata Pharmaceuticals,,
    Deborah Ferguson
  3. Hamon Center for Therapeutic Oncology Research,,
    Luc Girard, Michael Peyton & John D. Minna
  4. Simmons Cancer Center,,
    John D. Minna, Xian-Jin Xie & Michael A. White
  5. Department of Biochemistry, and,
    Carolyn Michnoff, Weihua Hao & Michael G. Roth
  6. Center for Biostatistics and Clinical Science, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA,
    Xian-Jin Xie

Authors

  1. Angelique W. Whitehurst
    You can also search for this author inPubMed Google Scholar
  2. Brian O. Bodemann
    You can also search for this author inPubMed Google Scholar
  3. Jessica Cardenas
    You can also search for this author inPubMed Google Scholar
  4. Deborah Ferguson
    You can also search for this author inPubMed Google Scholar
  5. Luc Girard
    You can also search for this author inPubMed Google Scholar
  6. Michael Peyton
    You can also search for this author inPubMed Google Scholar
  7. John D. Minna
    You can also search for this author inPubMed Google Scholar
  8. Carolyn Michnoff
    You can also search for this author inPubMed Google Scholar
  9. Weihua Hao
    You can also search for this author inPubMed Google Scholar
  10. Michael G. Roth
    You can also search for this author inPubMed Google Scholar
  11. Xian-Jin Xie
    You can also search for this author inPubMed Google Scholar
  12. Michael A. White
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toMichael A. White.

Ethics declarations

Competing interests

Reprints and permissions information is available at www.nature.com/reprints. The authors declare no competing financial interests.

Supplementary information

Supplementary Table 1

This file contains Supplementary Table 1 which shows full data set containing mean, S.D., p-values, and associated gene annotations from the genome-wide screen. (XLS 9352 kb)

Supplementary Table 2

This file contains Supplementary Table 2 which shows 5% FDR gene list. (XLS 70 kb)

Supplementary Table 3

This file contains Supplementary Table 3 which shows 2.5 percentile gene list. (XLS 68 kb)

Supplementary Table 4

This file contains Supplementary Table 4 which shows p-values and FDR values for genes described in Figure 2. (XLS 24 kb)

Supplementary Table 5

This file contains Supplementary Table 5 which shows siRNA sequences corresponding to the HC hit list. (XLS 39 kb)

Supplementary Table 6

This file contains Supplementary Table 6 which shows transfection conditions for all cell lines used in this study. (XLS 18 kb)

Supplementary Table 7

This file contains Supplementary Table 7 which shows primer sequences used for quantitative rtPCR. (XLS 19 kb)

Supplementary Information

This file contains Supplementary Figures 1-6 with Legends and Supplementary Methods (PDF 1110 kb)

Rights and permissions

About this article

Cite this article

Whitehurst, A., Bodemann, B., Cardenas, J. et al. Synthetic lethal screen identification of chemosensitizer loci in cancer cells.Nature 446, 815–819 (2007). https://doi.org/10.1038/nature05697

Download citation